Gurra P, Babu R, Pancholi B, Mohanta B, Garabadu D
Cytotechnology. 2024; 77(1):26.
PMID: 39735330
PMC: 11680541.
DOI: 10.1007/s10616-024-00687-2.
Tang Y, Liu Y, Fujita M
Glycoconj J. 2024; 41(6):395-405.
PMID: 39382616
PMC: 11735522.
DOI: 10.1007/s10719-024-10169-4.
Osher E, Anis Y, Singer-Shapiro R, Urshanski N, Unger T, Albeck S
Mol Ther Methods Clin Dev. 2024; 32(3):101300.
PMID: 39211733
PMC: 11357852.
DOI: 10.1016/j.omtm.2024.101300.
Faro D, Di Pino F, Rodolico M, Costanzo L, Losi V, Di Pino L
Genes (Basel). 2024; 15(8).
PMID: 39202460
PMC: 11354189.
DOI: 10.3390/genes15081101.
Faro D, Di Pino F, Monte I
Int J Mol Sci. 2024; 25(15).
PMID: 39125842
PMC: 11312754.
DOI: 10.3390/ijms25158273.
The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases.
Costagliola G, De Marco E, Massei F, Roberti G, Catena F, Casazza G
Ther Clin Risk Manag. 2024; 20:261-274.
PMID: 38770035
PMC: 11104440.
DOI: 10.2147/TCRM.S462996.
Animal Models for the Study of Gaucher Disease.
Cabasso O, Kuppuramalingam A, Lelieveld L, Van der Lienden M, Boot R, Aerts J
Int J Mol Sci. 2023; 24(22).
PMID: 38003227
PMC: 10671165.
DOI: 10.3390/ijms242216035.
Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment.
Yang Z, Gong M, Yang C, Chen C, Zhang K
Handb Exp Pharmacol. 2023; 281:103-140.
PMID: 37735301
DOI: 10.1007/164_2023_697.
A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution.
Chen Y, Tian W, Yasuda M, Ye Z, Song M, Mandel U
Front Bioeng Biotechnol. 2023; 11:1128371.
PMID: 36911201
PMC: 9999025.
DOI: 10.3389/fbioe.2023.1128371.
Genetic and phenotypic profile of Fabry disease in the population of Vale do Paraiba and Eastern São Paulo.
Paz O, Lacerda R, Modelli de Andrade L
J Bras Nefrol. 2023; 45(4):424-439.
PMID: 36745055
PMC: 10726653.
DOI: 10.1590/2175-8239-JBN-2022-0107en.
Engineering antibody and protein therapeutics to cross the blood-brain barrier.
Zhao P, Zhang N, An Z
Antib Ther. 2022; 5(4):311-331.
PMID: 36540309
PMC: 9759110.
DOI: 10.1093/abt/tbac028.
Mucopolysaccharidoses and the blood-brain barrier.
Sahin O, Thompson H, Goodman G, Li J, Urayama A
Fluids Barriers CNS. 2022; 19(1):76.
PMID: 36117162
PMC: 9484072.
DOI: 10.1186/s12987-022-00373-5.
Strategies for Manipulating Microglia to Determine Their Role in the Healthy and Diseased Brain.
Parajuli B, Koizumi S
Neurochem Res. 2022; 48(4):1066-1076.
PMID: 36085395
PMC: 9462627.
DOI: 10.1007/s11064-022-03742-6.
The therapeutic potential of bone marrow-derived macrophages in neurological diseases.
Zhou K, Han J, Wang Y, Xu Y, Zhang Y, Zhu C
CNS Neurosci Ther. 2022; 28(12):1942-1952.
PMID: 36066198
PMC: 9627381.
DOI: 10.1111/cns.13964.
IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport.
Boado R
Pharmaceutics. 2022; 14(7).
PMID: 35890374
PMC: 9322584.
DOI: 10.3390/pharmaceutics14071476.
Rare Diseases in Glycosphingolipid Metabolism.
Zhou H, Wu Z, Wang Y, Wu Q, Hu M, Ma S
Adv Exp Med Biol. 2022; 1372:189-213.
PMID: 35503182
DOI: 10.1007/978-981-19-0394-6_13.
Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.
Ezgu F, Alpsoy E, Bicik Bahcebasi Z, Kasapcopur O, Palamar M, Onay H
Orphanet J Rare Dis. 2022; 17(1):90.
PMID: 35236382
PMC: 8889663.
DOI: 10.1186/s13023-022-02215-x.
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme.
Arguello A, Mahon C, Calvert M, Chan D, Dugas J, Pizzo M
J Exp Med. 2022; 219(3).
PMID: 35226042
PMC: 8932535.
DOI: 10.1084/jem.20211057.
Chemoenzymatic glycan-selective remodeling of a therapeutic lysosomal enzyme with high-affinity M6P-glycan ligands. Enzyme substrate specificity is the name of the game.
Zhang X, Liu H, Meena N, Li C, Zong G, Raben N
Chem Sci. 2021; 12(37):12451-12462.
PMID: 34603676
PMC: 8480326.
DOI: 10.1039/d1sc03188k.
Gaucher disease type 1: the first experience of enzyme replacement therapy in pediatric practice in Moldova - case report.
Usurelu N, Blanita D, Boiciuc C, Hlistun V, Egorov V, Popovici E
Med Pharm Rep. 2021; 94(Suppl No 1):S57-S60.
PMID: 34527913
PMC: 8411813.
DOI: 10.15386/mpr-2232.
